Related Experiment Video
Updated: Mar 31, 2026

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
miR-30d Blocked Transforming Growth Factor β1-Induced Epithelial-Mesenchymal Transition by Targeting Snail in Ovarian
1Centers for *Translational Medicine and †Laboratory Medicine, the First Affiliated Hospital, Xi'an Jiaotong University College of Medicine, Xi'an, Shaanxi, People's Republic of China.
Objective:
MicroRNAs (miRs) are essential regulators of gene expression by suppressing translation or causing degradation of target mRNA. Growing evidence sheds light on the crucial roles of miR dysregulation in cancer development and progression. In this study, we focused on the role of miR-30d in transforming growth factor β1 (TGF-β1)-initiated epithelial-mesenchymal transition (EMT) in ovarian cancer cells.
Methods:
Transforming growth factor β1 (10 ng/mL) was used to initiate EMT in SKOV3 and 3AO cells. The expression of miR-30 family members was determined by quantitative real-time polymerase chain reaction. Messenger RNA and protein levels of E-cadherin, N-cadherin, vimentin, and Snail were detected by quantitative real-time polymerase chain reaction and Western blot, respectively. Cell migration and invasion capacities were evaluated by Transwell chamber assay. Luciferase activity assay was performed to verify the direct inhibition of Snail by miR-30d.
Results:
MiR-30b, MiR-30c, and MiR-30d were down-regulated during TGF-β1-induced EMT in SKOV3 and 3AO ovarian cancer cells. Restoration of miR-30d by miR-30d mimic reversed TGF-β1-induced EMT phenotypes including the morphological changes, expression pattern of molecular markers (E-cadherin, N-cadherin), and migratory and invasive capabilities in ovarian cancer cells. Furthermore, Snail was identified as the direct target of miR-30d.
Conclusions:
Our results revealed that miR-30d functioned as a suppressor of ovarian cancer progression by decreasing Snail expression and thus blocking TGF-β1-induced EMT process, suggesting the potentiality of miR-30d analogs to be used as therapeutics for ovarian cancer.
Insights
MicroRNA-30d (miR-30d) suppresses ovarian cancer progression by inhibiting epithelial-mesenchymal transition (EMT) and targeting Snail. This finding suggests miR-30d analogs could be potential ovarian cancer therapeutics.
Area of Science:
- Molecular Biology
- Cancer Research
- Gene Regulation
Background:
- MicroRNAs (miRs) regulate gene expression and their dysregulation is implicated in cancer.
- Epithelial-mesenchymal transition (EMT) is a key process in cancer development and metastasis.
- The role of miR-30d in transforming growth factor β1 (TGF-β1)-induced EMT in ovarian cancer requires further investigation.
Purpose of the Study:
- To investigate the role of miR-30d in TGF-β1-induced EMT in ovarian cancer cells.
- To identify the molecular mechanisms underlying miR-30d's function in ovarian cancer progression.
Main Methods:
- TGF-β1 was used to induce EMT in ovarian cancer cell lines (SKOV3 and 3AO).
- Quantitative real-time PCR and Western blot were used to assess gene and protein expression (E-cadherin, N-cadherin, vimentin, Snail).
- Cell migration and invasion assays were performed, and luciferase assays verified direct targeting of Snail by miR-30d.
Main Results:
- TGF-β1 induction led to down-regulation of miR-30b, miR-30c, and miR-30d in ovarian cancer cells.
- Restoring miR-30d expression reversed EMT phenotypes, including morphological changes and altered molecular marker expression.
- miR-30d directly targets and inhibits Snail expression, a key regulator of EMT.
Conclusions:
- miR-30d acts as a tumor suppressor in ovarian cancer by inhibiting TGF-β1-induced EMT.
- The mechanism involves the direct downregulation of Snail expression.
- miR-30d analogs hold potential as therapeutic agents for ovarian cancer treatment.
Related Concept Videos
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
MicroRNAs
MicroRNAs
Mitogens and the Cell Cycle

